» Articles » PMID: 29346228

Analgesia of Combined Femoral Triangle and Obturator Nerve Blockade Is Superior to Local Infiltration Analgesia After Total Knee Arthroplasty With High-Dose Intravenous Dexamethasone

Overview
Date 2018 Jan 19
PMID 29346228
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: High-dose intravenous dexamethasone reduces the postoperative opioid requirement and is often included in the multimodal analgesia strategy after total knee arthroplasty (TKA). Combined obturator nerve and femoral triangle blockade (OFB) reduces the opioid consumption and pain after TKA better than local infiltration analgesia (LIA). The question is whether preoperative high-dose intravenous dexamethasone would cancel out the superior analgesic effect of OFB compared with LIA. The aim was to evaluate the analgesic effect of OFB versus LIA after TKA when all patients received high-dose intravenous dexamethasone.

Methods: Eighty-two patients were randomly assigned either to OFB or LIA after primary unilateral TKA. All patients received 16 mg dexamethasone. Primary outcome was morphine consumption via patient-controlled analgesia during the first 20 postoperative hours. Secondary outcomes were pain, nausea, dizziness, and length of hospital stay.

Results: Seventy-four patients were included in the analysis. Median total intravenous morphine consumption during the first 20 postoperative hours was 6 mg (interquartile range [IQR], 2-18 mg) in the OFB group and 20 mg (IQR, 12-28 mg) in the LIA group. The 14-mg difference (95% confidence interval, 6.4-18.0 mg) was significant (P < 0.001). There was no difference in pain score at rest at 20 hours postoperatively: 2 (IQR, 1-4) in the OFB group and 3 (IQR, 2-5) in the LIA group.

Conclusions: Combined OFB reduces morphine consumption better than LIA after TKA even when all patients received high-dose intravenous dexamethasone.

Clinical Trial Registration: This study was registered at ClinicalTrials.gov, identifier NCT02374008.

Citing Articles

Advances in perioperative pain management for total knee arthroplasty: a review of multimodal analgesic approaches.

Zhao C, Liao Q, Yang D, Yang M, Xu P J Orthop Surg Res. 2024; 19(1):843.

PMID: 39696522 PMC: 11658298. DOI: 10.1186/s13018-024-05324-4.


Effect of Magnesium Sulfate Infusion on Postoperative Quality of Recovery in Patients Undergoing Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Trial.

Xu H, Hao C, Wang X, Du J, Zhang T, Zhang X Drug Des Devel Ther. 2024; 18:919-929.

PMID: 38560523 PMC: 10980840. DOI: 10.2147/DDDT.S444896.


Periarticular injection, iPACK block, and peripheral nerve block in pain management after total knee arthroplasty: a structured narrative review.

Domagalska M, Wieczorowska-Tobis K, Reysner T, Kowalski G Perioper Med (Lond). 2023; 12(1):59.

PMID: 37968690 PMC: 10652613. DOI: 10.1186/s13741-023-00346-8.


The effects of adding local infiltration analgesia of the knee to a multimodal pain protocol for total arthroplasty: A matched pair retrospective study.

Selznick A, Chhina T, Sennik V, Tam K, El Beheiry H Can J Pain. 2022; 3(1):98-105.

PMID: 35005398 PMC: 8730671. DOI: 10.1080/24740527.2019.1603077.


Comparing Analgesic Efficacy of a Novel Dual Subsartorial Block Using Two Different Volumes in Patients Undergoing Total Knee Arthroplasty: A Prospective, Double-Blind, Monocentric, Randomised Trial.

Sonawane K, Dixit H, Mistry T, Balavenkatasubramanian J Cureus. 2021; 13(12):e20488.

PMID: 34934599 PMC: 8683700. DOI: 10.7759/cureus.20488.